Barclays PLC holds 263,695 shares in Phibro (NASDAQ: PAHC)
Rhea-AI Filing Summary
Barclays PLC filed an amended Schedule 13G/A reporting beneficial ownership of 263,695 shares of Phibro Animal Health Corp-A common stock, representing 1.27% of the class. The filing shows Barclays has sole voting and sole dispositive power over the reported shares. The amendment is signed by a Barclays director on 05/14/2026.
Positive
- None.
Negative
- None.
Key Figures
Filing type: Schedule 13G/A
Beneficially owned: 263,695 shares
Percent of class: 1.27%
+4 more
7 metrics
Filing type
Schedule 13G/A
Amendment No. 1
Beneficially owned
263,695 shares
Common stock
Percent of class
1.27%
Reported ownership percentage
CUSIP
71742Q106
Phibro Animal Health Corp-A
Sole voting power
263,695 shares
Item 4(i)
Sole dispositive power
263,695 shares
Item 4(iii)
Signature date
05/14/2026
Signature by Barclays director
Key Terms
Schedule 13G/A, beneficially owned, sole dispositive power, parent holding company
4 terms
Schedule 13G/A regulatory
"filed an amended Schedule 13G/A reporting beneficial ownership"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially owned financial
"Amount beneficially owned: 263695"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 263695"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
parent holding company regulatory
"Identification and Classification of the Subsidiary Which Acquired the Security"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stake does Barclays PLC report in PHIBRO (PAHC)?
Barclays PLC reports beneficial ownership of 263,695 shares, equal to 1.27% of PHIBRO common stock. The filing is an amended Schedule 13G/A and lists sole voting and dispositive power over those shares.
When was the Schedule 13G/A for PAHC signed by Barclays?
The Schedule 13G/A amendment is signed by a Barclays director with a signature date of 05/14/2026. The filing header also references 03/31/2026 in the document metadata.
Which Barclays entities are identified in the filing for the PAHC position?
The filing names affiliated entities including Barclays Bank PLC, Barclays Capital Inc, and Barclays Capital Securities Ltd as relevant subsidiaries or broker-dealer affiliates in Item 7.
What CUSIP and class are reported for the PHIBRO holding?
The filing reports the CUSIP 71742Q106 and identifies the security as Common Stock of Phibro Animal Health Corp-A. The Schedule 13G/A format is used for passive or qualifying institutional holdings.